1. Home
  2. WTFCM vs BBIO Comparison

WTFCM vs BBIO Comparison

Compare WTFCM & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WTFCM
  • BBIO
  • Stock Information
  • Founded
  • WTFCM N/A
  • BBIO 2015
  • Country
  • WTFCM United States
  • BBIO United States
  • Employees
  • WTFCM 5903
  • BBIO N/A
  • Industry
  • WTFCM Major Banks
  • BBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • WTFCM Finance
  • BBIO Health Care
  • Exchange
  • WTFCM Nasdaq
  • BBIO Nasdaq
  • Market Cap
  • WTFCM N/A
  • BBIO 8.0B
  • IPO Year
  • WTFCM N/A
  • BBIO 2019
  • Fundamental
  • Price
  • WTFCM $24.95
  • BBIO $42.78
  • Analyst Decision
  • WTFCM
  • BBIO Strong Buy
  • Analyst Count
  • WTFCM 0
  • BBIO 14
  • Target Price
  • WTFCM N/A
  • BBIO $58.85
  • AVG Volume (30 Days)
  • WTFCM N/A
  • BBIO 3.3M
  • Earning Date
  • WTFCM N/A
  • BBIO 07-31-2025
  • Dividend Yield
  • WTFCM N/A
  • BBIO N/A
  • EPS Growth
  • WTFCM N/A
  • BBIO N/A
  • EPS
  • WTFCM N/A
  • BBIO N/A
  • Revenue
  • WTFCM N/A
  • BBIO $127,415,000.00
  • Revenue This Year
  • WTFCM N/A
  • BBIO $102.05
  • Revenue Next Year
  • WTFCM N/A
  • BBIO $54.69
  • P/E Ratio
  • WTFCM N/A
  • BBIO N/A
  • Revenue Growth
  • WTFCM N/A
  • BBIO N/A
  • 52 Week Low
  • WTFCM N/A
  • BBIO $21.72
  • 52 Week High
  • WTFCM N/A
  • BBIO $45.48
  • Technical
  • Relative Strength Index (RSI)
  • WTFCM 26.14
  • BBIO 62.54
  • Support Level
  • WTFCM $25.07
  • BBIO $39.65
  • Resistance Level
  • WTFCM $25.36
  • BBIO $45.48
  • Average True Range (ATR)
  • WTFCM 0.02
  • BBIO 1.56
  • MACD
  • WTFCM -0.03
  • BBIO 0.15
  • Stochastic Oscillator
  • WTFCM 2.40
  • BBIO 60.90

About WTFCM Wintrust Financial Corporation Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock Series D

Wintrust Financial Corp is a financial holding company that provides community-oriented, personal, and commercial banking services to customers generally located in the Chicago metropolitan area, southern Wisconsin, northwest Indiana, and western Michigan. The company provides specialty finance services, including financing for the payment of property and casualty insurance premiums and life insurance premiums, and wealth management services to customers in its market area. The company's operations consist of three primary segments: community banking, specialty finance, and wealth management. The company generates the majority of its revenue from the community banking segment.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: